Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
USD 25.3
(-0.06%)
USD 25.3
(-0.06%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 10.86 Million USD | 66.14% |
| 2022 | 6.54 Million USD | 55.11% |
| 2021 | 4.21 Million USD | 6.44% |
| 2020 | 3.96 Million USD | 20.02% |
| 2019 | 3.3 Million USD | 79.99% |
| 2018 | 1.83 Million USD | -18.45% |
| 2017 | 2.24 Million USD | 22.16% |
| 2016 | 1.84 Million USD | 30.38% |
| 2015 | 1.41 Million USD | 278.82% |
| 2014 | 372.73 Thousand USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 10.81 Million USD | -0.52% |
| 2024 Q2 | 9.42 Million USD | -12.81% |
| 2023 Q2 | 8.55 Million USD | -5.92% |
| 2023 Q4 | 10.86 Million USD | 21.77% |
| 2023 Q3 | 8.92 Million USD | 4.31% |
| 2023 FY | 10.86 Million USD | 66.14% |
| 2023 Q1 | 9.09 Million USD | 39.02% |
| 2022 Q4 | 6.54 Million USD | 23.81% |
| 2022 Q3 | 5.28 Million USD | 2.94% |
| 2022 Q2 | 5.13 Million USD | 16.74% |
| 2022 FY | 6.54 Million USD | 55.11% |
| 2022 Q1 | 4.39 Million USD | 4.24% |
| 2021 FY | 4.21 Million USD | 6.44% |
| 2021 Q4 | 4.21 Million USD | 7.44% |
| 2021 Q1 | 4.49 Million USD | 13.48% |
| 2021 Q3 | 3.92 Million USD | 0.56% |
| 2021 Q2 | 3.9 Million USD | -13.19% |
| 2020 Q4 | 3.96 Million USD | -0.3% |
| 2020 Q2 | 3.84 Million USD | -3.71% |
| 2020 Q3 | 3.97 Million USD | 3.46% |
| 2020 Q1 | 3.98 Million USD | 20.84% |
| 2020 FY | 3.96 Million USD | 20.02% |
| 2019 Q4 | 3.3 Million USD | 35.12% |
| 2019 Q2 | 2.65 Million USD | 11.06% |
| 2019 Q1 | 2.38 Million USD | 30.21% |
| 2019 FY | 3.3 Million USD | 79.99% |
| 2019 Q3 | 2.44 Million USD | -7.88% |
| 2018 Q1 | 2.04 Million USD | -9.29% |
| 2018 Q4 | 1.83 Million USD | -27.34% |
| 2018 Q3 | 2.52 Million USD | 13.9% |
| 2018 Q2 | 2.21 Million USD | 8.63% |
| 2018 FY | 1.83 Million USD | -18.45% |
| 2017 FY | 2.24 Million USD | 22.16% |
| 2017 Q4 | 2.24 Million USD | -5.27% |
| 2017 Q3 | 2.37 Million USD | 29.59% |
| 2017 Q2 | 1.83 Million USD | -10.37% |
| 2017 Q1 | 2.04 Million USD | 11.03% |
| 2016 Q4 | 1.84 Million USD | -3.21% |
| 2016 FY | 1.84 Million USD | 30.38% |
| 2016 Q2 | 1.44 Million USD | 16.87% |
| 2016 Q3 | 1.9 Million USD | 31.99% |
| 2016 Q1 | 1.23 Million USD | -12.68% |
| 2015 Q3 | 1.27 Million USD | 60.53% |
| 2015 FY | 1.41 Million USD | 278.82% |
| 2015 Q1 | 711 Thousand USD | 90.75% |
| 2015 Q2 | 793 Thousand USD | 11.53% |
| 2015 Q4 | 1.41 Million USD | 10.92% |
| 2014 Q1 | 50.12 Thousand USD | 0.0% |
| 2014 Q4 | 372.73 Thousand USD | 6.13% |
| 2014 Q3 | 351.2 Thousand USD | 103.3% |
| 2014 Q2 | 172.75 Thousand USD | 244.62% |
| 2014 FY | 372.73 Thousand USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | - USD | -Infinity% |
| BIMI International Medical Inc. | 7.65 Million USD | -41.974% |
| China Jo-Jo Drugstores, Inc. | 17.16 Million USD | 36.684% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 10.86 Million USD | 0.0% |
| Leafly Holdings, Inc. | - USD | -Infinity% |
| Leafly Holdings, Inc. | - USD | -Infinity% |
| LifeMD, Inc. | 2.75 Million USD | -293.742% |
| LifeMD, Inc. | 2.75 Million USD | -293.742% |
| TRxADE HEALTH, Inc. | 968.00 USD | -1122523.967% |
| PetMed Express, Inc. | 28.55 Million USD | 61.945% |
| Walgreens Boots Alliance, Inc. | 8.32 Billion USD | 99.869% |